Literature DB >> 27686824

Metastasis: an early event in cancer progression.

Yijun Hu1,2, Xiya Yu3, Guixia Xu1, Shanrong Liu4.   

Abstract

PURPOSE: Metastasis is the leading cause of death for a majority of cancer patients, and thus the need to understand the biology of metastasis becomes increasingly acute. When metastasis is initiated in tumor progression remains obscure. Better understanding of mechanisms regulating acquisition of metastatic ability in tumor cells will provide novel therapeutic targets and prevention of metastasis in clinics accompanied with the treatment of the primary tumor might be helpful in reducing metastasis-related mortality.
METHODS: A literature search was performed in multiple electronic databases. Research papers from clinical reports to experimental studies on metastasis were analyzed.
RESULTS: The article discusses tumor heterogeneity and genomic instability in the context of metastasis and tumor cell dissemination. And then we review biological mechanism of metastasis at an early stage in both intracellular (CSCs and CTCs) and extracellular (microenvironment) context. Finally, current development of anti-metastatic therapies is summarized.
CONCLUSIONS: Metastasis could be initiated at an early point of tumor progression. Therefore, early intervention on metastasis should be applied among cancer patients in clinical settings.

Entities:  

Keywords:  Cancer stem cells (CSCs); Circulating tumor cells (CTCs); Early event; Metastasis; Microenvironment

Mesh:

Year:  2016        PMID: 27686824     DOI: 10.1007/s00432-016-2279-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  128 in total

1.  High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

Authors:  Ana M Gonzalez-Angulo; Jennifer K Litton; Kristine R Broglio; Funda Meric-Bernstam; Ronjay Rakkhit; Fatima Cardoso; Florentia Peintinger; Emer O Hanrahan; Aysegul Sahin; Merih Guray; Denis Larsimont; Francesco Feoli; Heidi Stranzl; Thomas A Buchholz; Vicente Valero; Richard Theriault; Martine Piccart-Gebhart; Peter M Ravdin; Donald A Berry; Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

2.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

Authors:  H Bissig; J Richter; R Desper; V Meier; P Schraml; A A Schäffer; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 3.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

4.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Authors:  Xin Lu; Euphemia Mu; Yong Wei; Sabine Riethdorf; Qifeng Yang; Min Yuan; Jun Yan; Yuling Hua; Benjamin J Tiede; Xuemin Lu; Bruce G Haffty; Klaus Pantel; Joan Massagué; Yibin Kang
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

5.  Involvement of insulin receptor substrate 2 in mammary tumor metastasis.

Authors:  Julie A Nagle; Zhefu Ma; Maura A Byrne; Morris F White; Leslie M Shaw
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 6.  The functional and clinical roles of osteopontin in cancer and metastasis.

Authors:  K A Furger; R K Menon; A B Tuck; V H Bramwell; A F Chambers
Journal:  Curr Mol Med       Date:  2001-11       Impact factor: 2.222

7.  Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity.

Authors:  Amy Chen; Ileana Cuevas; Paraic A Kenny; Hiroshi Miyake; Kimberley Mace; Cyrus Ghajar; Aaron Boudreau; Mina J Bissell; Mina Bissell; Nancy Boudreau
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

Review 8.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

Review 9.  Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance.

Authors:  Felix Schmidt; Thomas Efferth
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-16

Review 10.  The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.

Authors:  Brock Humphries; Chengfeng Yang
Journal:  Oncotarget       Date:  2015-03-30
View more
  11 in total

1.  Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer.

Authors:  Désirée Gül; Andrea Schweitzer; Aya Khamis; Shirley K Knauer; Guo-Bin Ding; Laura Freudelsperger; Ioannis Karampinis; Sebastian Strieth; Jan Hagemann; Roland H Stauber
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

Review 2.  Metastasis prevention: targeting causes and roots.

Authors:  A A Schegoleva; A A Khozyainova; T S Gerashchenko; L D Zhuikova; Evgeny V Denisov
Journal:  Clin Exp Metastasis       Date:  2022-03-26       Impact factor: 4.510

3.  Increased cancer-specific mortality of very small size in carcinoembryonic antigen-elevated rectal cancer.

Authors:  Haiqiang Pan; Junhui Cui; Ke Cai; Yena Zhou
Journal:  Ann Transl Med       Date:  2019-09

4.  Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.

Authors:  Hongtao Wei; Xiaotong Yu; Xiaowei Xue; Hui Liu; Menglong Wang; Yingying Li; Xuejiang Wang; Huiguo Ding
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

5.  Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients.

Authors:  Pavel Dvorak; Viktor Hlavac; Beatrice Mohelnikova-Duchonova; Vaclav Liska; Martin Pesta; Pavel Soucek
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

6.  NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis.

Authors:  Xiaoping Zhao; Zhi Xu; Haoseng Li
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

Review 7.  CTCs 2020: Great Expectations or Unreasonable Dreams.

Authors:  Elisabetta Rossi; Francesco Fabbri
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

8.  Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.

Authors:  Baoguang Hu; Xiaokun Tian; Yanbin Li; Yangchun Liu; Tao Yang; Zhaodong Han; Jiajia An; Lingqun Kong; Yuming Li
Journal:  Cancer Med       Date:  2020-02-20       Impact factor: 4.452

9.  ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.

Authors:  Sara Charmsaz; Ben Doherty; Sinéad Cocchiglia; Damir Varešlija; Attilio Marino; Nicola Cosgrove; Ricardo Marques; Nolan Priedigkeit; Siobhan Purcell; Fiona Bane; Jarlath Bolger; Christopher Byrne; Philip J O'Halloran; Francesca Brett; Katherine Sheehan; Kieran Brennan; Ann M Hopkins; Stephen Keelan; Petra Jagust; Stephen Madden; Chiara Martinelli; Matteo Battaglini; Steffi Oesterreich; Adrian V Lee; Gianni Ciofani; Arnold D K Hill; Leonie S Young
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

10.  MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling.

Authors:  Yang Wang; Jing Zhang; Yang-Jia Li; Nan-Nan Yu; Wan-Ting Liu; Jun-Ze Liang; Wen Wen Xu; Zheng-Hua Sun; Bin Li; Qing-Yu He
Journal:  J Exp Clin Cancer Res       Date:  2021-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.